This article is available online at http://www.jlr.org kinase pathways in regulating phosphoinositide signaling; however, all signaling pathways are subject to negative as well as positive control, pointing to a key role for inositol phospholipid phosphatases in cell and tissue regulation in health and disease. This review focuses upon this aspect of regulation, considering the importance of the many phosphatases that can act upon phosphoinositides, and we further consider the importance of each in malignancy.
PHOSPHOINOSITIDE 3-KINASESIn mammals, the phosphoinositide 3-kinase (PI3K) isoforms responsible for phosphorylating the 3-hydroxyl group of the inositol headgroup of PtdIns, PtdIns(4)P, and PtdIns(4,5)P 2 have been divided into three classes: class I, class II, and class III.In response to activation of cell surface receptors, class I PI3Ks are responsible for phosphorylating PtdIns(4,5)P 2 to generate PtdIns(3,4,5)P 3 ( 3 ). There are four class I PI3Ks that exist as heterodimers of regulatory and catalytic subunits. The four distinct catalytic subunits, p110 ␣ , - , -␥ , and -␦ , are further divided into class IA (p110 ␣ , - , and -␦ ) and class IB (p110 ␥ ). Class IA PI3Ks bind the SH2 domain containing the p85 family of regulatory subunits (p85 ␣ , p85  , and p55) that bind to protein tyrosine phosphate residues in activated receptors, thus relieving p85-mediated Abstract Signaling through the phosphoinositide 3-kinase pathways mediates the actions of a plethora of hormones, growth factors, cytokines, and neurotransmitters upon their target cells following receptor occupation. Overactivation of these pathways has been implicated in a number of pathologies, in particular a range of malignancies. The tight regulation of signaling pathways necessitates the involvement of both stimulatory and terminating enzymes; inappropriate activation of a pathway can thus result from activation or inhibition of the two signaling arms . The focus of this review is to discuss, in detail, the activities of the identifi ed families of phosphoinositide phosphatase expressed in humans, and how they regulate the levels of phosphoinositides implicated in promoting malignancy. A series of tightly regulated lipid kinase and phosphatase enzyme activities coordinately convert phosphatidylinositol (PtdIns) into a network of phosphorylated derivatives, collectively called phosphoinositides. These differ in the number and position of the phosphate groups on the inositol head group: three PtdIns monophosphate isomers [PtdIns(3)P, PtdIns(4)P, and PtdIns(5)P], three PtdIns bisphosphate isomers [PtdIns(3,4)P 2 , PtdIns(3,5) P 2 , and PtdIns(4,5)P 2 ], and a single trisphosphate isomer [PtdIns(3,4,5)Phosphoinositide signaling is an extensively studied topic with clear evidence linking the pathway from the kinase to activation of AKT and TOR to a number of disease states. While these include malignancies, there is also strong evidence for other diseases, such as overgrowth syndromes. Most studies have focused upon the importance of the ...